Loading company details...
Beta
Latest Form 4 (Sep 11, 2026): Daniel E. Pinto (Director): Grant/Award of 113 shares, $31.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Daniel E. Pinto | Grant/Award | 113 | $31.3K |
| Sep 11, 2026 | Eugene A. Woods | Grant/Award | 136 | $37.5K |
| Sep 11, 2026 | Marillyn A. Hewson | Grant/Award | 181 | $50.0K |
| Sep 4, 2026 | Timothy Schmid, EVP, WW Chair, MedTech | Exercise/Conversion | 11,070 | $1.46M |
| Aug 18, 2026 | Jennifer L. Taubert, EVP, WWC. Innovative Medicine | Exercise/Conversion | 15,000 | $1.74M |
| Aug 14, 2026 | Joaquin Duato, CEO and Chairman of the Board | Exercise/Conversion | 123,291 | $14.26M |
| Aug 7, 2026 | Joaquin Duato, CEO and Chairman of the Board | Sale | 41,957 | $10.83M |
| Aug 7, 2026 | Elizabeth Forminard, EVP, Chief Legal Officer | Exercise/Conversion | 9,344 | $1.23M |
| Jul 21, 2026 | Vanessa Broadhurst, EVP, Global Corp Affairs | Exercise/Conversion | 11,129 | $1.44M |
| Jun 12, 2026 | Kathryn E. Wengel, EVP, Chief TO and Risk Officer | Exercise/Conversion | 10,000 | $1.16M |